In 2006, Tsai et al. initially demonstrated that CD147 and MMP-9 were overexpressed in renal cell carcinomas by immunohistochemistry and upregulation of CD147 in tumor cells was associated with poor prognosis of patients with clear cell renal cell carcinoma (CRCC) [73]. This evidence concerns the gene BSG and chromophobe renal cell carcinoma.